Course Overview
The Advanced Weight Management Certification: GLP-1 Agonists (Semaglutide) and Emerging Therapies by Empire Medical Training is designed for licensed healthcare professionals—including physicians, nurse practitioners, physician assistants, and nurses—who aim to integrate evidence-based weight loss solutions into their practice. This comprehensive program covers the latest advancements in weight management, focusing on FDA-approved pharmaceutical treatments such as GLP-1 receptor agonists (e.g., semaglutide), hormonal protocols, and adjunctive therapies.
Participants will engage in detailed instruction on patient assessment, personalized treatment planning, and the implementation of effective weight loss strategies. All necessary course materials are included in the tuition. Continuing Medical Education (CME) credits are available upon completion. There are no prerequisites.
What to Expect
As a provider considering this course, you can expect to gain:
- In-depth knowledge of GLP-1 receptor agonists: Understand the mechanisms, benefits, and administration protocols of medications like semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®) for effective weight management.
- Expertise in hormonal weight loss protocols: Learn to evaluate and address hormonal imbalances that contribute to obesity, incorporating therapies that optimize patient outcomes.
- Skills in adjunctive weight loss therapies: Gain proficiency in utilizing supplements, MIC injections, Vitamin B-12, and other supportive treatments to enhance weight loss programs.
- Comprehensive patient assessment abilities: Develop the capability to perform thorough evaluations, including laboratory workups, to create personalized and effective weight loss plans.
- Strategies for integrating weight loss services into your practice: Acquire practical approaches to implement and market weight management programs, enhancing patient care and practice revenue.
.png)
